Top

European Archives of Oto-Rhino-Laryngology

Published in:

08-09-2023 | Metastasis | Head and Neck

The prognostic value of lymphatic metastatic size in head and neck squamous cell carcinoma

Authors: Wenqian Xie, Peiliang Lin, Zhijuan Li, Huan Wan, Faya Liang, Jianming Fan, Lanlan Deng, Xiaoming Huang

Published in: European Archives of Oto-Rhino-Laryngology | Issue 1/2024

Abstract

Background

Lymphatic metastatic size was proved to predict prognosis in different types of carcinomas, except in head and neck squamous cell carcinoma (HNSCC) located in hypopharynx, oropharynx and supraglottic region et al. The aim of this study is to evaluate the prognostic value of lymphatic metastatic size in HNSCC, which may guide clinical decision-making in practice.

Methods

From 2008 to 2022, 171 patients, who were diagnosed as HNSCC in our center, were included. The demographic data, clinicopathological characteristics and lymphatic metastatic size were recorded and analyzed using the Kaplan–Meier method and Cox regression analysis.

Results

Among 171 patients, 107 cases were hypopharyngeal cancer, 38 cases supraglottic cancer and 26 cases oropharyngeal cancer. The median of lymphatic metastatic size was 8 mm (range 0–46). According to lymphatic metastatic size, the patients were assigned to three subgroups: Group I (0 mm), Group II ( ≤ 10 mm) and Group III (> 10 mm). Kaplan–Meier analysis with log rank test revealed that Group I and Group II had similar locoregional control rate, distant metastasis free probability, disease-free survival and overall survival (all p > 0.05), whereas Group III had significant worse prognosis. Adjusted for demographic and other clinicopathological characteristics, lymphatic metastatic size was an independent predictor of disease-free survival and overall survival in HNSCC.

Conclusions

Lymphatic metastatic size was an independently prognostic factor in HNSCC, which may assist in postoperative adjuvant treatment decisions.

Available only for authorised users

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108. https://doi.org/10.3322/caac.21262CrossRefPubMed

Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F et al (2017) The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin 67:51–64. https://doi.org/10.3322/caac.21384CrossRefPubMed

Cerezo L, Millán I, Torre A, Aragón G, Otero J (1992) Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases. Cancer 69:1224–1234. https://doi.org/10.1002/cncr.2820690526CrossRefPubMed

Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS et al (2017) Metastatic lymph node burden and survival in oral cavity cancer. J Clin Oncol 35:3601–3609. https://doi.org/10.1200/jco.2016.71.1176CrossRefPubMedPubMedCentral

Yonemori A, Kondo S, Matsuno Y, Ito T, Nakanishi Y, Miyamoto M et al (2010) Prognostic impact of regional lymph node micrometastasis in patients with node-negative biliary cancer. Ann Surg 252:99–106. https://doi.org/10.1097/SLA.0b013e3181e33c0aCrossRefPubMed

Barresi V, Reggiani Bonetti L, Vitarelli E, Di Gregorio C, de Leon MP, Barresi G (2012) Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases. Am J Surg Pathol 36:66–72. https://doi.org/10.1097/PAS.0b013e31822d3008CrossRefPubMed

Jeon MJ, Yoon JH, Han JM, Yim JH, Hong SJ, Song DE et al (2013) The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma. Eur J Endocrinol 168:219–225. https://doi.org/10.1530/eje-12-0744CrossRefPubMed

Dutta SW, Volaric A, Morgan JT, Chinn Z, Atkins KA, Janowski EM (2019) Pathologic evaluation and prognostic implications of nodal micrometastases in breast cancer. Semin Radiat Oncol 29:102–110. https://doi.org/10.1016/j.semradonc.2018.11.001CrossRefPubMed

Hruban RH, Westra WH, Phelps TH, Isacson C (1996) Surgical pathology dissection

10.

Monica B. Lemos EO (2019) Atlas of surgical pathology grossing (Atlas of Anatomic Pathology) 1st ed. 2019 Edition, pp 11–2

11.

Wang Q, Wang S, Sun Z, Cao M, Zhao X (2022) Evaluation of log odds of positive lymph nodes in predicting the survival of patients with non-small cell lung cancer treated with neoadjuvant therapy and surgery: a SEER cohort-based study. BMC Cancer 22:801. https://doi.org/10.1186/s12885-022-09908-3CrossRefPubMedPubMedCentral

12.

Yang J, Huang H, Li W, Ran S, Hu J, Zhang Y et al (2022) A prognostic nomogram based on log odds of positive lymph nodes to predict overall survival for non-metastatic bladder cancer patients after radical cystectomy. Curr Oncol (Toronto, Ont) 29:6834–6846. https://doi.org/10.3390/curroncol29100539CrossRef

13.

Cao ZX, Weng X, Huang JS, Long X (2022) Prognostic value of LODDS in medullary thyroid carcinoma based on competing risk model and propensity score matching analysis. Updates Surg 74:1551–1562. https://doi.org/10.1007/s13304-022-01320-7CrossRefPubMed

14.

Machens A, Lorenz K, Weber F, Dralle H (2022) Superiority of metastatic lymph node ratio over number of node metastases and TNM/AJCC N classification in predicting cancer-specific survival in medullary thyroid cancer. Head Neck 44:2717–2726. https://doi.org/10.1002/hed.27181CrossRefPubMed

15.

Wang J, Liu Y, Shayan G, Ma Y, Yi J (2022) Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1–2N1 oral cavity carcinoma. Radiother Oncol 172:83–90. https://doi.org/10.1016/j.radonc.2022.05.009CrossRefPubMed

16.

Sato F, Shimada Y, Li Z, Watanabe G, Maeda M, Imamura M (2001) Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg 88:426–432. https://doi.org/10.1046/j.1365-2168.2001.01687.xCrossRefPubMed

17.

Tojima Y, Nagino M, Ebata T, Uesaka K, Kamiya J, Nimura Y (2003) Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg 237:201–207. https://doi.org/10.1097/01.Sla.0000048446.18118.FcCrossRefPubMedPubMedCentral

18.

Lang BH, Tang AH, Wong KP, Shek TW, Wan KY, Lo CY (2012) Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma. Ann Surg Oncol 19:3472–3478. https://doi.org/10.1245/s10434-012-2385-4CrossRefPubMedPubMedCentral

19.

Dhar DK, Yoshimura H, Kinukawa N, Maruyama R, Tachibana M, Kohno H et al (2005) Metastatic lymph node size and colorectal cancer prognosis. J Am Coll Surg 200:20–28. https://doi.org/10.1016/j.jamcollsurg.2004.09.037CrossRefPubMed

20.

Lee YM, Park JH, Cho JW, Hong SJ, Yoon JH (2019) The definition of lymph node micrometastases in pathologic N1a papillary thyroid carcinoma should be revised. Surgery 165:652–656. https://doi.org/10.1016/j.surg.2018.09.015CrossRefPubMed

21.

Andersson Y, Bergkvist L, Frisell J, de Boniface J (2018) Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. Breast Cancer Res Treat 171:359–369. https://doi.org/10.1007/s10549-018-4820-0CrossRefPubMed

22.

Choi KH, Song JH, Hong JH, Lee YS, Kang JH, Sun DI et al (2022) Importance of lymph node ratio in HPV-related oropharyngeal cancer patients treated with surgery and adjuvant treatment. PLoS ONE 17:e0273059. https://doi.org/10.1371/journal.pone.0273059CrossRefPubMedPubMedCentral

23.

Kouka M, Al-Ahmar E, Büntzel J, Kaftan H, Böger D, Müller A et al (2022) The log odds of positive neck lymph nodes is a superior lymph node predictor for overall survival in head and neck cancer: a population-based analysis in Germany. Eur Arch Oto-rhino-laryngol 279:3587–3595. https://doi.org/10.1007/s00405-021-07176-8CrossRef

24.

van den Brekel MW (2000) Lymph node metastases: CT and MRI. Eur J Radiol 33:230–238. https://doi.org/10.1016/s0720-048x(99)00145-xCrossRefPubMed

Title: The prognostic value of lymphatic metastatic size in head and neck squamous cell carcinoma
Authors: Wenqian Xie
Peiliang Lin
Zhijuan Li
Huan Wan
Faya Liang
Jianming Fan
Lanlan Deng
Xiaoming Huang
Publication date: 08-09-2023
Publisher: Springer Berlin Heidelberg
Keyword: Metastasis
Published in: European Archives of Oto-Rhino-Laryngology / Issue 1/2024
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-023-08199-z

2024 ASCO Annual Meeting

Springer Medicine

The prognostic value of lymphatic metastatic size in head and neck squamous cell carcinoma

Abstract

Background

Methods

Results

Conclusions

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2024

Congenital laryngo-tracheo-esophageal clefts: updates from a quaternary care pediatric airway unit

Treatment efficacy of 532-nm diode laser glottoplasty in patients with sulcus vocalis: a prospective study

Impact of dysplasia at resection margin on oncologic outcome after curative resection of oral tongue squamous cell carcinoma: significance of high-grade dysplastic resection margin

Olfactory training with four and eight odors: comparison with clinical testing and olfactory bulb volumetrics

Post-implantation clinical cost analysis between transcutaneous and percutaneous bone conduction devices

The effect of anxiety and depression on cognition in older adults with severe-to-profound hearing loss

Treatment efficacy of 532-nm diode laser glottoplasty in patients with sulcus vocalis: a prospective study